pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 14·1 min read
save

FDA commissioner Marty Makary exits, acting head Kyle Diamantas named as podcast discusses impact and Senate health race

May 14, 2026·read at STAT ↗RegulatoryNeutral

The Readout Loud podcast episode focused on health politics, featuring a discussion of FDA commissioner Marty Makary's departure.

Hosts examined why Makary is leaving, which of his policies might remain, and introduced his acting replacement, Kyle Diamantas.

The conversation also turned to the closely watched Republican Senate primary in Louisiana, where Senate health committee chair Bill Cassidy faces two challengers.

Insights were provided by FDA reporter Lizzy Lawrence and Washington correspondent Chelsea Cirruzzo.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Makary’s departure and Cassidy’s tenuous Senate seat”

read at STAT ↗
566 words · retrieved May 14
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ELI LILLY COLILLYSERVIERUltragenyx Pharmaceutical Inc.
drugs
Obesity
topics
Oncology2CAR-TDuchenne Muscular DystrophyGene Therapy (AAV)ObesityRare Disease

related stories

  • Dec 22Fierce Biotech Fundraising Tracker '26: Matchpoint makes $150M; KymaThera corrals $80MFierce Biotech
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 3STAT+: Legend Biotech emerged as a rare market winnerSTAT
  • Dec 23Fierce Biotech Layoff Tracker 2026: Caribou cuts staff, halts pipeline; Foghorn reduces workforce by 40%Fierce Biotech
  • 20h agoFDA review docs spark Revolution sell-off; Zealand diabetes data underwhelm analystsBioPharma Dive